Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Gene Therapies for Tumor Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Application:
Hospital
Clinic
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Gene Therapies for Tumor Treatment Industry Overview
-
1.1.1 Gene Therapies for Tumor Treatment Market Scope and Market Segments
-
1.1.2 Gene Therapies for Tumor Treatment Industry Characteristics
-
1.1.3 Global and China Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Gene Therapies for Tumor Treatment Production Value and Growth Rate (2017-2028)
-
1.2 Global Gene Therapies for Tumor Treatment Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Gene Induced Immunotherapy
-
1.2.2 Oncolytic Virotherapy
-
1.2.3 Gene Transfer
-
1.3 Global Gene Therapies for Tumor Treatment Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Clinic
-
1.3.3 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Gene Therapies for Tumor Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Gene Therapies for Tumor Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Gene Therapies for Tumor Treatment Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Gene Therapies for Tumor Treatment Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Gene Therapies for Tumor Treatment Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Gene Therapies for Tumor Treatment Industry Porter's Five Forces Model Analysis
-
2.2.3 Gene Therapies for Tumor Treatment Industry PEST Analysis
-
2.3 Gene Therapies for Tumor Treatment Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Gene Therapies for Tumor Treatment Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Gene Therapies for Tumor Treatment Industry
Chapter 3 Global and China Gene Therapies for Tumor Treatment Market, by Manufacturer
-
3.1 Global and China Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Gene Therapies for Tumor Treatment Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Gene Therapies for Tumor Treatment Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Gene Therapies for Tumor Treatment Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Gene Therapies for Tumor Treatment Market Top 3 Players
Chapter 4 Global and China Gene Therapies for Tumor Treatment Market, by Type (2017-2028)
-
4.1 Gene Therapies for Tumor Treatment Market Trend, by Type
-
4.2 Global Gene Therapies for Tumor Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Gene Therapies for Tumor Treatment Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Gene Therapies for Tumor Treatment Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Gene Therapies for Tumor Treatment Price Trend, by Type (2017-2028)
-
4.3 China Gene Therapies for Tumor Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Gene Therapies for Tumor Treatment Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Gene Therapies for Tumor Treatment Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Gene Therapies for Tumor Treatment Price Trend, by Type (2017-2028)
Chapter 5 Global and China Gene Therapies for Tumor Treatment Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Gene Therapies for Tumor Treatment Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Gene Therapies for Tumor Treatment Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Gene Therapies for Tumor Treatment Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Gene Therapies for Tumor Treatment Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Gene Therapies for Tumor Treatment Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Gene Therapies for Tumor Treatment Market Analysis
-
7.1 North America Gene Therapies for Tumor Treatment Market, by Type
-
7.2 North America Gene Therapies for Tumor Treatment Market, by Application
-
7.3 North America Gene Therapies for Tumor Treatment Market Analysis and Forecast, by Country
-
7.3.1 United States Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Gene Therapies for Tumor Treatment Market Analysis
-
8.1 Europe Gene Therapies for Tumor Treatment Market, by Type
-
8.2 Europe Gene Therapies for Tumor Treatment Market, by Application
-
8.3 Europe Gene Therapies for Tumor Treatment Market Analysis and Forecast, by Country
-
8.3.1 Germany Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Gene Therapies for Tumor Treatment Market Analysis
-
9.1 APAC Gene Therapies for Tumor Treatment Market, by Type
-
9.2 APAC Gene Therapies for Tumor Treatment Market, by Application
-
9.3 APAC Gene Therapies for Tumor Treatment Market Analysis and Forecast, by Country
-
9.3.1 China Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Market Analysis
-
10.1 Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Market, by Type
-
10.2 Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Market, by Application
-
10.3 Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Gene Therapies for Tumor Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Gene Therapies for Tumor Treatment Company Profiles
-
11.1 Novartis
-
11.1.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Novartis Gene Therapies for Tumor Treatment Product Profiles, Application and Specification
-
11.1.3 Novartis Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Kite Pharma
-
11.2.1 Kite Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Kite Pharma Gene Therapies for Tumor Treatment Product Profiles, Application and Specification
-
11.2.3 Kite Pharma Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Amgen
-
11.3.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Amgen Gene Therapies for Tumor Treatment Product Profiles, Application and Specification
-
11.3.3 Amgen Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Shanghai Sunway
-
11.4.1 Shanghai Sunway Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Shanghai Sunway Gene Therapies for Tumor Treatment Product Profiles, Application and Specification
-
11.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Sibiono
-
11.5.1 Sibiono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Sibiono Gene Therapies for Tumor Treatment Product Profiles, Application and Specification
-
11.5.3 Sibiono Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Gene Therapies for Tumor Treatment Industry Investment Prospect and Risk Assessment
-
12.1 Gene Therapies for Tumor Treatment Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Gene Therapies for Tumor Treatment Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Production Value and Growth Rate (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Production Value and Growth Rate (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Market Size and Growth Rate of Gene Induced Immunotherapy (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Market Size and Growth Rate of Oncolytic Virotherapy (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Market Size and Growth Rate of Gene Transfer (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Market Size and Growth Rate of Clinic (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Gene Therapies for Tumor Treatment Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Gene Therapies for Tumor Treatment Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Gene Therapies for Tumor Treatment Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Gene Therapies for Tumor Treatment Market Share, by Manufacturer in 2021
-
Figure Global and China Gene Therapies for Tumor Treatment Market Share, by Manufacturer in 2022
-
Table Global Gene Therapies for Tumor Treatment Sales Volume, by Type (2017-2028)
-
Table Global Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Table Global Gene Therapies for Tumor Treatment Sales Value, by Type (2017-2028)
-
Table Global Gene Therapies for Tumor Treatment Sales Value Share, by Type (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Price Trend, by Type (2017-2028)
-
Table China Gene Therapies for Tumor Treatment Sales Volume, by Type (2017-2028)
-
Table China Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Table China Gene Therapies for Tumor Treatment Sales Value, by Type (2017-2028)
-
Table China Gene Therapies for Tumor Treatment Sales Value Share, by Type (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Price Trend, by Type (2017-2028)
-
Table Global Gene Therapies for Tumor Treatment Sales Volume, by Application (2017-2028)
-
Table Global Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Table Global Gene Therapies for Tumor Treatment Sales Value, by Application (2017-2028)
-
Table Global Gene Therapies for Tumor Treatment Sales Value Share, by Application (2017-2028)
-
Figure Global Gene Therapies for Tumor Treatment Sales Value Share, by Application (2017-2028)
-
Table China Gene Therapies for Tumor Treatment Sales Volume, by Application (2017-2028)
-
Table China Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Table China Gene Therapies for Tumor Treatment Sales Value, by Application (2017-2028)
-
Table China Gene Therapies for Tumor Treatment Sales Value Share, by Application (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Sales Value Share, by Application (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
Figure North America Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Production, Import, Consumption and Export (2017-2022)
-
Table North America Gene Therapies for Tumor Treatment Sales Volume, by Type (2017-2028)
-
Table North America Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Figure North America Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Table North America Gene Therapies for Tumor Treatment Sales Volume, by Application (2017-2028)
-
Table North America Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure North America Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure United States Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure United States Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Canada Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Table Europe Gene Therapies for Tumor Treatment Sales Volume, by Type (2017-2028)
-
Table Europe Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Figure Europe Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Table Europe Gene Therapies for Tumor Treatment Sales Volume, by Application (2017-2028)
-
Table Europe Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure Europe Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure Germany Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure UK Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure UK Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure France Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure France Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Italy Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Spain Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Poland Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Russia Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Table APAC Gene Therapies for Tumor Treatment Sales Volume, by Type (2017-2028)
-
Table APAC Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Figure APAC Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Table APAC Gene Therapies for Tumor Treatment Sales Volume, by Application (2017-2028)
-
Table APAC Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure APAC Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure China Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Japan Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure India Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure India Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Gene Therapies for Tumor Treatment Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Gene Therapies for Tumor Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Gene Therapies for Tumor Treatment Sales Value and Growth Rate (2017-2028)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Kite Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Kite Pharma Product Profiles, Application and Specification
-
Table Kite Pharma Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shanghai Sunway Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shanghai Sunway Product Profiles, Application and Specification
-
Table Shanghai Sunway Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sibiono Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sibiono Product Profiles, Application and Specification
-
Table Sibiono Gene Therapies for Tumor Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
